Skip to main content
诺思兰德 logo

诺思兰德 — Investor Relations & Filings

Ticker · 920047 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 539 across all filing types
Latest filing 2025-08-31 Remuneration Information
Country CN China
Listing Beijing Stock Exchange 920047

About 诺思兰德

https://www.northland-bio.com/

Northland Biotech focuses on the research, development, and commercialization of gene therapies and recombinant protein pharmaceuticals. The company’s primary therapeutic areas include cardiovascular diseases, peripheral arterial diseases, and ophthalmology. Its core R&D pipeline features NL003, a hepatocyte growth factor gene therapy targeting critical limb ischemia, and NL005, a recombinant human thymosin beta 4 for treating myocardial ischemia. Beyond its innovative pipeline, the company maintains advanced manufacturing facilities for biologics and ophthalmic preparations, producing a range of specialized eye drops. By leveraging its proprietary technology platforms, Northland Biotech aims to provide effective treatments for chronic and degenerative conditions through advanced molecular medicine.

Recent filings

Filing Released Lang Actions
董事、高级管理人员薪酬管理制度
Remuneration Information Classification · 95% confidence The document is titled '董事、高级管理人员薪酬管理制度' which translates to 'Remuneration Management System for Directors and Senior Management'. It details the company's internal rules and policies regarding the compensation of directors and senior executives, including salary structure, payment methods, adjustment principles, and governance of remuneration. There is no financial data or report of results, but rather a detailed policy document on remuneration. This matches the definition of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors. The document is not an announcement or a brief summary but a full policy document, so it is not RNS or RPA. The document length is 2520 characters, which is relatively short but sufficient for a remuneration policy. Therefore, the correct classification is DEF 14A with high confidence.
2025-08-31 Chinese
内部审计制度
Audit Report / Information Classification · 95% confidence The document is titled as an internal audit system policy of Beijing Northland Biotechnology Co., Ltd., detailing the internal audit department's structure, responsibilities, procedures, and authority. It is a comprehensive internal governance document related to internal audit practices and internal control systems. There is no indication that this is a standalone audit report with audit opinions or financial statement audits, nor is it a full annual or interim financial report. It is not a certification or a brief announcement but a detailed internal control and audit governance document. This fits best under 'Audit Report / Information (AR)' as it relates to internal audit policies and procedures, which are part of audit information but not a full annual report or financial statement filing. The document length is 4325 characters, which is substantial and contains detailed content, not a mere announcement or certification. Therefore, the classification is AR with high confidence. FY 2025
2025-08-31 Chinese
内幕信息知情人登记管理制度
Governance Information Classification · 95% confidence The document is titled as an "Insider Information Insider Registration Management System" issued by Beijing Northland Biotechnology Co., Ltd. It details internal policies and procedures for managing insider information, including definitions, scope, registration, confidentiality, and responsibilities. It includes references to regulatory laws and stock exchange rules but does not contain financial statements, earnings data, or report summaries. The document is a formal announcement of an internal governance policy related to insider information management, approved by the board on a specific date. It is not a financial report, earnings release, or regulatory filing of financial results. It fits best under Governance Information (CGR) as it details internal rules and governance practices regarding insider information management.
2025-08-31 Chinese
关于取消监事会并修订《公司章程》公告
Governance Information Classification · 95% confidence The document is a detailed announcement from Beijing Northland Biotechnology Co., Ltd. regarding the cancellation of the supervisory board and amendments to the company's articles of association. It includes extensive revisions to the company's charter, referencing relevant laws and regulations such as the Company Law, Securities Law, and listing rules of the Beijing Stock Exchange. The content focuses on corporate governance, shareholder rights, board responsibilities, and related legal provisions. There is no financial data, earnings information, or audit results presented. The document is not a report of financial performance but rather a governance-related announcement about changes to the company's internal rules and structure. Therefore, it fits best under the category of Governance Information (CGR). The document length (15,000 characters) and detailed content support a high confidence in this classification.
2025-08-31 Chinese
股东会议事规则
Governance Information Classification · 100% confidence The document is titled as "北京诺思兰德生物技术股份有限公司股东会议事规则" which translates to "Beijing Northland Biotechnology Co., Ltd. Shareholders Meeting Rules." It details the rules and procedures for convening and conducting shareholders' meetings, including voting procedures, proposal submissions, meeting notices, and other governance-related matters. It references the company's articles of association, relevant laws, and regulatory requirements. There is no financial data, earnings information, or audit content. The document is a detailed governance framework related to shareholder meetings and internal company rules. Therefore, it fits best under Governance Information (CGR). The document length is substantial (9869 characters), indicating it is the full text of the rules, not just an announcement or summary.
2025-08-31 Chinese
会计师事务所选聘制度
Governance Information Classification · 95% confidence The document is titled '会计师事务所选聘制度' which translates to 'Accounting Firm Selection System'. It details the internal procedures, requirements, and governance related to the selection, appointment, and supervision of the company's external auditors (accounting firms). It includes sections on the general principles, quality requirements, selection procedures, supervision, and penalties related to the appointment of accounting firms. There is no actual audit report, financial statements, or audit results included. Instead, it is a governance document outlining policies and procedures for auditor selection and oversight. This fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document is 3675 characters long, which is relatively short and focused on policy rather than financial data or audit results. Therefore, the appropriate classification is CGR with high confidence.
2025-08-31 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.